STO:CAMX

Camurus AB · STO · Healthcare · SEK · FY for 2025

Figures on this page computed 2026-11-08 12:41 UTC

Last close

n/aSEK

Market data

  • 58.9xP/E

    Price / Earnings per Share (diluted)

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    SEK
    • computed
    • Computed from the filing for 2025
  • 113.3%ROIC

    NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    SEK
    • Computed from the filing for 2025
    • Computed from the filing for 2025
    • Computed from the filing for 2025
    • Computed from the filing for 2025
    • Computed from the filing for 2025
    • Computed from the filing for 2025
  • 32.5%Net margin

    Net Income / Revenue x 100

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    SEK
    • Computed from the filing for 2025
    • Computed from the filing for 2025
  • 32.3%FCF margin

    Free Cash Flow / Revenue x 100

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    SEK
    • Computed from the filing for 2025
    • Computed from the filing for 2025
  • 0.03Debt/equity

    Total Debt / Shareholders' Equity

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    SEK
    • Computed from the filing for 2025
    • Computed from the filing for 2025
  • n/aDividend yield

    We do not hold this figure for this company, so there is nothing to place.

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    SEK
    • computed

Five bars, one line

lens 7 of 9
2.81x
12.32x
27.24x
2.94x
n/a
SalesProfitFree cash flowDebtPrice
Each bar against this company's own average; the line is that average.
Computed2025
Computed2025
Computed2025
Computed2025
Market datan/a

Each against its own average

4 of 5 read

Except where said otherwise: Computed from the filing for 2025

  • Sales2.81x

    Its own average over 10 years, 806.6M.

  • Profit12.32x

    Its own average over 10 years, 59.7M.

  • Free cash flow27.24x

    Its own average over 10 years, 26.8M.

  • Debt2.94x

    Its own average over 7 years, 36.0M.

  • Pricen/a

    Its own average over 0 years. Market data

Free cash flow is furthest from its own average, at 27.24 times.

Sales is 2.81 times its own 10-year average; Profit is 12.32 times its own 10-year average; Free cash flow is 27.24 times its own 10-year average; Debt is 2.94 times its own 7-year average.

Every figure in this lens

Except where said otherwise: Computed from the filing for 2025

  • Sales against its own 10-year average2.81
    Source
    computed
    Statement
    income
    Fiscal year
    2025
    Reported in
    SEK
  • Profit against its own 10-year average12.32
    Source
    computed
    Statement
    income
    Fiscal year
    2025
    Reported in
    SEK
  • Free cash flow against its own 10-year average27.24
    Source
    computed
    Statement
    income
    Fiscal year
    2025
    Reported in
    SEK
  • Debt against its own 7-year average2.94
    Source
    computed
    Statement
    income
    Fiscal year
    2025
    Reported in
    SEK
  • Price against its own 0-year averagen/aMarket data

    Not held.

    Source
    market
    Reported in
    SEK

Filed figures cite the filing they come from; figures marked Market data are quotes as of the date shown. Not a recommendation and not advice.

Past figures are not a forecast. Anything we modelled is labelled as ours. You can lose money on any security.